| Dr Heather Young O'laughlin, AUD | |
|
6110 Main St Ste D, Zachary, LA 70791-4079 | |
| (225) 658-4154 | |
| (225) 658-4155 |
| Full Name | Dr Heather Young O'laughlin |
|---|---|
| Gender | Female |
| Speciality | Audiologist-hearing Aid Fitter |
| Location | 6110 Main St Ste D, Zachary, Louisiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326294455 | NPI | - | NPPES |
| 1620645 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 81453 (Texas) | Secondary |
| 237600000X | Audiologist-hearing Aid Fitter | 5018 (Louisiana) | Primary |
| Provider Name | Kelsey-seybold Medical Group, Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1013915255 PECOS PAC ID: 9739093527 Enrollment ID: O20031117000204 |
News Archive
Scientists at The Scripps Research Institute have found a new approach to the "reprogramming" of ordinary adult cells into stem cells.
Two oral targeted drugs approved for metastatic kidney cancer worked equally well, but one proved superior in tolerability, according to results of a large international clinical trial led by researchers at Dana-Farber Cancer Institute.
A collaboration between the Drugs for Neglected Diseases Initiative (DNDi) and the Institut Pasteur Korea (IP-K) to spur the fight against neglected diseases has been established.
Researchers from Korea report that, compared with conventional sedation, balanced propofol sedation using propofol in combination with midazolam and meperidine, provided higher health care provider satisfaction, better patient cooperation, and similar adverse event profiles in patients undergoing therapeutic endoscopic procedures.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Heather Young O'laughlin, AUD 11511 Shadow Creek Pkwy, Pearland, TX 77584-7298 Ph: (713) 442-0000 | Dr Heather Young O'laughlin, AUD 6110 Main St Ste D, Zachary, LA 70791-4079 Ph: (225) 658-4154 |
News Archive
Scientists at The Scripps Research Institute have found a new approach to the "reprogramming" of ordinary adult cells into stem cells.
Two oral targeted drugs approved for metastatic kidney cancer worked equally well, but one proved superior in tolerability, according to results of a large international clinical trial led by researchers at Dana-Farber Cancer Institute.
A collaboration between the Drugs for Neglected Diseases Initiative (DNDi) and the Institut Pasteur Korea (IP-K) to spur the fight against neglected diseases has been established.
Researchers from Korea report that, compared with conventional sedation, balanced propofol sedation using propofol in combination with midazolam and meperidine, provided higher health care provider satisfaction, better patient cooperation, and similar adverse event profiles in patients undergoing therapeutic endoscopic procedures.
› Verified 4 days ago